Now showing items 1-1 of 1

    • Mortality Aacross two ART trials enrolling at ≤200 vs ≤350 CD4 cells uL in Kenya 

      Chung, Michael; Kiarie, James N; Yatich, Nelly; Njoroge, Julia; Kiptiness, Catherine; Sakr, Samah; John-Stewart, Grace; Frenkel, Lisa (University of Nairobi, 2015-02-26)
      Background: In 2011, Kenyan HIV treatment guidelines changed from initiating ART at a CD4 of ≤200 to ≤350 cells/uL. We compared 6-month mortality in 2 research cohorts, one enrolled before and one after the 2011 ART ...